Andmed seisuga: 21.07.2024 17:13 (GMT+3)

Tallinna Farmaatsiatehas: Balance sheet, as at 31.12.2000

28.02.2001, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

BALANCE SHEET, AS AT 31.12.2000

Consolidated/unaudited
in thousand EEK 31.12.2000 31.12.1999

A S S E T S

CURRENT ASSETS
Cash and bank accounts 715 1,782
Customer receivables
ACCOUNTS RECEIVABLE 4,979 3,443
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE - -
Total 4,979 3,443

Other receivables
RECEIVABLES FROM PARENT COMPANY 30,375 22,601
OTHER SHORT-TERM RECEIVABLES 98 3,048
Total 30,473 25,649

Accrued income 37 37

Prepaid expenses 582 473

Inventories
RAW MATERIAL 12,134 12,380
WORK-IN-PROGRESS 565 879
FINISHED GOODS 11,654 12,415
PREPAYMENTS TO SUPPLIERS 1,331 1,266
Total 25,684 26,940

TOTAL CURRENT ASSETS 62,471 58,324

NON-CURRENT ASSETS

Long-term investments 449 480

Fixed assets
FIXED ASSETS IN NET BOOK VALUE 33,636 33,561
CONSTRUCTION IN PROGRESS 119 1,344
Total 33,755 34,905

Intangible assets 3,216 3,218

TOTAL NON-CURRENT ASSETS 37,420 38,604

TOTAL ASSETS 99,891 96,928


LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 7,703 7,703
SHORT-TERM BANK LOANS 496 418
Total 8,200 8,121

Customers prepayments 44
Accounts payable 13,714 13,130
Other payables 3,882 1,006
Taxes payable 701 1,575

Accrued expenses 2,364 1,969

TOTAL CURRENT LIABILITIES 28,860 25,846

NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 24,055 30,812
PAYABLES TO PARENT COMPANY 24,351 28,232

TOTAL NON-CURRENT LIABILITIES 48,406 59,044

TOTAL LIABILITIES 77,266 84,890

SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12,500 12,500
RESERVES 2,316 2,316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2,779 -8,560
PROFIT (LOSS) FOR FINANCIAL YEAR 10,587 5,782
SHAREHOLDERS’ EQUITY TOTAL 22,625 12,037

LIABILITIES AND SHAREHOLDERS’ EQUITY 9,243 5,104


Raivo Unt
Financial Director
+372 612 0201

Kaubeldavad väärtpaberid

Aktsiad
Võlakirjad
Fondid

Turuinfo

Statistika
Kauplemine
Indeksid
Oksjonid

Turureeglid

Reeglid ja hinnad
Järelevalve

Alusta siit

Ettevõttele
Investorile
Liikmetele
First North turu nõustajatele

Uudised

Nasdaqi uudised
Ettevõtete uudised
Kalender

Meist

Ettevõttest
Kontorid